Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention. Is the Current Antiplatelet Therapy Adequate?

Journal of the American College of Cardiology

Volumn 49, Issue 6, 2007, Pages 657-666

  Bliden, Kevin P ^a   DiChiara, Joseph ^a   Tantry, Udaya S ^a   Bassi, Ashwani K ^a   Chaganti, Srivasavi K ^a   Gurbel, Paul A ^a  

^a SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN;

AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STROKE; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; THROMBOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECURRENCE; STENTS; THROMBELASTOGRAPHY; TICLOPIDINE;

EID: 33846837282     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.10.050     Document Type: Article

References (22)

1. Tantry U.S., Bliden K.P., and Gurbel P.A. Resistance to antiplatelet drugs: current status and future research. Expert Opin Pharmacother 6 (2005) 2027-2045
2. Gurbel P.A., Bliden K.P., Hayes K.M., and Tantry U. Platelet activation in myocardial ischemic syndromes. Expert Rev Cardiovasc Ther 2 (2004) 535-545
3. Gurbel P.A., Bliden K.P., Zaman K.A., Yoho J.A., Hayes K.M., and Tantry U.S. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEARPLATELETS) study. Circulation 111 (2005) 1153-1159
4. Gurbel P.A., Bliden K.P., Samara W., et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 46 (2005) 1827-1832
5. Gurbel P.A., Bliden K.P., Guyer K., et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 46 (2005) 1820-1826
6. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
7. Gurbel P.A., Bliden K.P., Hayes K.M., Yoho J.A., Herzog W.R., and Tantry U.S. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 45 (2005) 1392-1396
8. Tantry U.S., Bliden K.P., and Gurbel P.A. What is the best measure of thrombotic risks- pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?. Catheter Cardiovasc Interv 66 (2005) 597
9. Patti G., Colonna G., Pasceri V., Pepe L.L., Montinaro A., and Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Circulation 111 (2005) 2099-2106
10. Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
11. Barragan P., Bouvier J.L., Roquebert P.O., et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv 59 (2003) 295-302
12. Gurbel P.A., Bliden K.P., and Tantry U.S. Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS-1b study. J Am Coll Cardiol 48 (2006) 2186-2191
13. Gurbel P.A., and Bliden K.P. Durability of platelet inhibition by clopidogrel. Am J Cardiol 91 (2003) 1123-1125
14. O'shea J.C., Madan M., Cantor W.J., et al. Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. Am Heart J 140 (2000) 834-839
15. Rivard G.E., Brummel-Ziedins K.E., Mann K.G., Fan L., Hofer A., and Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haemost 3 (2005) 2039-2043
16. Kawasaki J., Katori N., Kodaka M., Miyao H., and Tanaka K. Electron microscopic evaluations of clot morphology during thromboelastography. Anesth Analg 99 (2004) 1440-1444
17. Bliden K.P., Tantry U., Zaman K., et al. High platelet reactivity is a risk factor for post-discharge ischemic complications following elective coronary stenting. J Am Coll Cardiol 47 (2005) 45B
18. Tantry U.S., Bliden K.P., and Gurbel P.A. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 46 (2005) 1705-1709
19. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST-elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
20. Singh M., Williams B.A., Gersh B.J., et al. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial. J Am Coll Cardiol 47 (2006) 34-39
21. Heptinstall S., Johnson A., Glenn J.R., and White A.E. Adenine nucleotide metabolism in human blood-important roles for leukocytes and erythrocytes. J Thromb Haemost 10 (2005) 2331-2339
22. Kastrati A., Beckerath N., Joost A., Pogatsa-Murray G., Gorchakova O., and Schomig A. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy. Circulation 110 (2004) 1916-1919